ArticleFrontiers in oncology2024

The survival and safety of metastatic hepatocellular carcinoma treated with lenalidomide as second-line therapy: a case report and review of the literature.

Tao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.